Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Karnauchow TM, Tolson DL, Harrison BA, Altman E, Lublin DM, Dimock K.

J Virol. 1996 Aug;70(8):5143-52.

2.

Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.

Karnauchow TM, Dawe S, Lublin DM, Dimock K.

J Virol. 1998 Nov;72(11):9380-3.

3.

Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.

Haddad A, Nokhbeh MR, Alexander DA, Dawe SJ, Grisé C, Gulzar N, Dimock K.

J Virol. 2004 Mar;78(6):2674-81.

4.

Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.

Shafren DR, Dorahy DJ, Ingham RA, Burns GF, Barry RD.

J Virol. 1997 Jun;71(6):4736-43.

5.

Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.

Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP.

Virology. 1998 May 10;244(2):302-14.

6.

Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.

Shafren DR, Dorahy DJ, Thorne RF, Kinoshita T, Barry RD, Burns GF.

J Immunol. 1998 Mar 1;160(5):2318-23.

7.

Sialic acid functions in enterovirus 70 binding and infection.

Alexander DA, Dimock K.

J Virol. 2002 Nov;76(22):11265-72.

8.

Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.

Ohta R, Imai M, Fukuoka Y, Miwa T, Okada N, Okada H.

Microbiol Immunol. 1999;43(11):1045-56.

9.

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Clarkson NA, Kaufman R, Lublin DM, Ward T, Pipkin PA, Minor PD, Evans DJ, Almond JW.

J Virol. 1995 Sep;69(9):5497-501.

10.

Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF.

Spiller OB, Goodfellow IG, Evans DJ, Almond JW, Morgan BP.

J Infect Dis. 2000 Jan;181(1):340-3.

PMID:
10608785
11.
12.

Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.

Spiller OB, Goodfellow IG, Evans DJ, Hinchliffe SJ, Morgan BP.

J Gen Virol. 2002 Jan;83(Pt 1):45-52.

PMID:
11752699
13.

Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.

Johansson ES, Xing L, Cheng RH, Shafren DR.

J Virol. 2004 Nov;78(22):12603-12.

14.

Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.

Newcombe NG, Johansson ES, Au G, Lindberg AM, Barry RD, Shafren DR.

J Virol. 2004 Feb;78(3):1431-9.

15.

Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.

Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, Küpper JH, Lindberg AM, Kandolf R.

J Med Virol. 2002 Jun;67(2):224-33.

PMID:
11992583
16.
17.
18.

Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.

Kramer B, Huber M, Kern C, Klingel K, Kandolf R, Selinka HC.

Virus Res. 1997 May;48(2):149-56.

PMID:
9175253
19.

The replication of certain Coxsackie B virus strains in CHO cells.

Frisk G, Elfström T, Diderholm H.

J Virol Methods. 2001 Nov;98(2):161-5.

PMID:
11576643
20.

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Powell RM, Ward T, Evans DJ, Almond JW.

J Virol. 1997 Dec;71(12):9306-12. Erratum in: J Virol 1998 Jan;72(1):890.

Supplemental Content

Support Center